Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: Implications for treatment and survival

Oncogene

Volumn 23, Issue 4, 2004, Pages 1000-1004

  Marsit, Carmen J ^a   Liu, Mei ^a   Nelson, Heather H ^a   Posner, Marshall ^b   Suzuki, Makoto ^c   Kelsey, Karl T ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

BRCA; Fanconi Anemia; HNSCC; Methylation; NSCLC

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA CROSS LINKING; DRINKING BEHAVIOR; FANCONI ANEMIA; FEMALE; GENE INACTIVATION; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MALE; METHYLATION; MOUTH CARCINOMA; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SOLID TUMOR;

AGED; ALCOHOL DRINKING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; DNA METHYLATION; DNA-BINDING PROTEINS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENES, BRCA1; GENES, BRCA2; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEINS; SMOKING; SURVIVAL ANALYSIS;

NICOTIANA TABACUM;

EID: 1342301467     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207256     Document Type: Article

References (26)

1. Alter BP. (1996). Am. J. Hematol., 53, 99-110.
2. Auerbach AD and Wolman SR. (1976). Nature, 261, 494-496.
3. Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S and Karlan BY. (2000). Cancer Res., 60, 5329-5333.
4. D'Andrea AD and Grompe M. (2003). Nat. Rev. Cancer, 3, 23-34.
5. Ehrlich M. (2002). Oncogene, 21, 5400-5413.
6. Esteller M, Corn PG, Baylin SB and Herman JG. (2001). Cancer Res., 61, 3225-3229.
7. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB and Herman JG. (2000). J. Natl. Cancer Inst., 92, 564-569.
8. Fang JY and Xiao SD. (2001). J. Gastroenterol. Hepatol., 16, 960-968.
9. Gras E, Cortes J, Diez O, Alonso C, Matias-Guiu X, Baiget M and Prat J. (2001). Cancer, 92, 787-795.
10. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M and Kelsey KT. (2002). Oncogene, 21, 4231-4236.
11. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
12. Ishida R and Buchwald M. (1982). Cancer Res., 42, 4000-4006.
13. Joenje H and Patel KJ. (2001). Nat. Rev. Genet., 2, 446-457.
14. Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ and Kelsey KT. (2001a). Oncogene, 20, 1765-1770.
15. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ and Kelsey KT. (2001b). Cancer Res., 61, 3419-3424.
16. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro P, Hanenberg H and Auerbach AD. (2003). Blood, 101, 1249-1256.
17. Miyamoto K, Fukutomi T, Asada K, Wakazono K, Tsuda H, Asahara T, Sugimura T and Ushijima T. (2002). Jpn. J. Clin. Oncol., 32, 79-84.
18. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC and Kelsey KT. (1999). J. Natl. Cancer Inst., 91, 2032-2038.
19. Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB and Yarbrough WG. (1997). Oncogene, 14, 811-818.
20. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD and Mulshine JL. (1996). J. Cell Biochem. Suppl., 24, 32-91.
21. Potter JD. (1999). J. Natl. Cancer Inst., 91, 916-932.
22. Rice JC, Ozcelik H, Maxeiner P, Andrulis I and Futscher BW. (2000). Carcinogenesis, 21, 1761-1765.
23. Rothman K and Keller A. (1972). J. Chronic Dis., 25, 711-716.
24. Sasaki MS and Tonomura A. (1973). Cancer Res., 33, 1829-1836.
25. Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC and D'Andrea AD. (2003). Nat. Med., 9, 568-574.
26. Wang X, Christiani DC, Wiencke JK, Fischbein M, Xu X, Cheng TJ, Mark E, Wain JC and Kelsey KT. (1995). Cancer Epidemiol. Biomarkers Prev., 4, 543-548.